Anand,Yusuf,Xie,et al. The Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulation and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357:217-227

Abstract

available at http://www.ncbi.nlm.nih.gov/ pubmed/17634457

Keywords

peripheral arterial occlusion disease anticoagulation antiplatelets

Get full access to this article

View all access options for this article.

References

Johnson WC , Williford WO Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg. 2002;35:413-421.

Bhatt DL , Fox KA , Hacke W. , et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354: 1706-1717.

Sarac TP , Huber TS , Back MR , et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg. 1998 ;28:446-457.

Tangelder MJ , Lawson JA , Algra A. , Eikelboom BC Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery. J Vasc Surg. 1999;30:701-709.

Norgren L. , Hiatt WR , Dormandy JA , Nehler MR , Harris KA , Fowkes FG Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-S67.

Smith SC Jr , Blair SN , Bonow RO , et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38:1581-1583.